Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07313371 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder

StatusRecruiting
PhasePhase 4
Started2026-01-28
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 24, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-02-20
Not Yet Recruiting→Recruiting Study Identification, Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Completion date2027-02→2027-07
Start dateestimated 2025-12→confirmed 2026-01-28
Study sites0→1
Study title+4 characters
Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine/ and Crack Use Disorder
2025-12-16
Original filing
This is a single-center, randomized intervention study in a volunteer population of patients with cocaine/crack use disorder to evaluate the pharmacological treatment of cocaine/crack craving, comparing the drug clonidine with the active placebo clonazepam.
Trial Details
NCT Number NCT07313371
Lead Sponsor University of Sao Paulo General Hospital
Conditions Cocaine Use Disorder, Crack Abuse or Dependence
Enrollment 36 participants
Start Date 2026-01-28
Primary Completion 2026-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-24